How AI And Machine Learning Will Impact CMC
Source: Entegris, Inc.
CMC experts Brian Kirk, Ph.D. (Merck, Minerva, Takeda) and Blair McNeill, Ph.D. (Amgen, Bayer, Alkermes, Roivant) offer some forward-looking thoughts on how AI and Machine Learning will impact CMC, and CMC-related regulatory interactions, in the not-too-distant future. Excerpted from the Bioprocess Online Live event Data-Driven CMC For PD Speed, Regulatory Efficiency.
View the full presentation here.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
Entegris, Inc.
This website uses cookies to ensure you get the best experience on our website. Learn more